Sovaldi has had more than its fair share of attention this year, but most of it seems to be centered around the pricing and not the benefits. When trying to understand the reasoning behind the high price, are the right questions being asked? Can the price be justified when looking at long term cuts to medical costs and health benefits? Take a look around the world- many countries other than the U.S. have Health Technology Assessment (HTA) agencies evaluating the effectiveness and/or cost-effectiveness of such drugs. What questions are they asking? What answers have they found? Learn more here. (Source: Daniel Liden, Yin Ho, parmaphorum, 8/21/14).
You are here: / / The Politics Of Pharma Pricing: Are We Asking The Right Questions?